Finally, we found that the myeloid cells subgroup in the HNSCC group highly expressed the marker genes of M2 macrophages such as CD163 and CD209, indicating that the tumor promoting effect of myeloid cells in the HNSCC group was stronger than that of leukoplakia (Fig. S5). The gene discussed is CD163; the disease is neoplasm.